No Detail Found!

Tshoma: a rare pituitary tumor

Author(s)
Muhammad Salman Aamir Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan
Tahir Ghaffar Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan
Muhammad Qasim : Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan
Mian Sameer Ahmed Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex, Peshawar, Pakistan
Afrasiyab Khalil Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex, Peshawar, Pakistan
Ali Sibtain Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex, Peshawar, Pakistan
Abstract
INTRODUCTION: TSH-secreting pituitary adenomas (TSHoma) or thyrotropinoma are rare pituitary tumors that secrete an abnormal Thyroid Stimulating Hormone (TSH) which constitutes up to 1% - 2% of all pituitary adenomas. Patients often remain misdiagnosed for years. This case is reported to emphasize the importance of diagnosing it early and accurately to ensure timely management and relief of symptoms before perpetual damage is done. CASE DESCRIPTION: We report a case of a 29 years old patient from Peshawar, Pakistan who was referred to Endocrine Unit Hayatabad Medical Complex Peshawar - Pakistan for the review of his persistently raised TSH despite optimal dosing of thyroxine for 2 years. He was initially diagnosed and treated for hyperthyroidism with Neomercazole and then with radioactive iodine (RAI). Post-RAI he developed hypothyroidism and was subsequently treated with optimal doses of thyroxine. Despite optimal doses of thyroxine, TSH remains elevated. Previous thyroid function tests also showed persistently raised T3, T4 and raised TSH. Patient was clinically thyrotoxic. MRI findings reveals macro adenoma and was resected by neurosurgeon and advised Endocrine follow up visit in OPD after surgery. CONCLUSION: TSHoma is highly under diagnosed. It is important to consider the pitfalls in diagnosis where normal or low alpha sub unit levels could lead to dubious differentials. The use of advance technology i.e. functional MRI scans to confirm diagnosis should be carried out early on leading to timely treatment options including radiotherapy and surgery.
Publication Details
Page(s) 11-0
DOI DOI not available
Published Journal: Khyber Medical University Journal, Volume: 13, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Thyrotropin (MeSH), Triiodothyronine (MeSH), Pituitary Neoplasms (MeSH), Iodine Radioisotopes (MeSH), TSHoma (Non-MeSH), Thyrotropinoma (Non-MeSH), Pituitary macroadenoma (Non-MeSH), Thyroid Hormones (MeSH), Thyroxine (MeSH), TSH-secreting pituitary adenomas (Non-MeSH)
0

Citations

0

Downloads

85

Views